A Phase II Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of A Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF) in Subjects With Clostridium Difficile Infection (CDI).
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2013
At a glance
- Drugs Clostridium difficile vaccine (Primary)
- Indications Clostridium infections
- Focus Pharmacodynamics; Therapeutic Use
- 22 Dec 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-004907-69).
- 29 Jun 2012 Actual patient number 116 added as reported by ClinicalTrials.gov.
- 29 Jun 2012 Actual end date (1 Jun 2012) added as reported by ClinicalTrials.gov.